Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
Enrolling by invitation · NCT05423977 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors | HER2-positive Advanced Solid Tumor | Enrolling by invitation | Phase 1 | 2025-09-30 | NCT05423977 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou Adcoris Biopharmacy Co., Ltd | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| PKUCare Luzhong Hospital | Zigong | China | 1 |